Endo Pharmaceuticals Inc. v. Impax Laboratories, Inc.
1:12-cv-08317
Overview
Parties
Defendant
Impax Laboratories, Inc. Operating Company
Represented By
4 Attorneys ListedCounter Claimant
Thorx Laboratories, Inc. Operating Company
Represented By
4 Attorneys ListedCounter Defendant
Court & Judges
Court
District Court, S.D. New York (nysd)
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 2 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | Asserted Patent | View Official Patent → |
| 🇬🇧 United Kingdom | United Kingdom Counterpart | View Official Patent → |
Amneal Pharmaceuticals, LLC v. Endo Pharmaceuticals, Inc.
Amneal Pharmaceuticals, LLC v. Endo Pharmaceuticals Inc.
Purdue Pharma L.P. v. Abhai, LLC
Purdue Pharma L.P. v. Amneal Pharmaceuticals LLC
Purdue Pharma L.P. v. PAR Pharmaceutical, Inc.
Purdue Pharma L.P. v. Amneal Pharmaceuticals, LLC
Endo Pharmaceuticals Inc. v. Roxane Laboratories, Inc.
Purdue Pharma L.P. v. Impax Laboratories, Inc.
Endo Pharmaceuticals Inc. v. Actavis Inc.
Endo Pharmaceuticals Inc. v. Amneal Pharmaceuticals, LLC
Endo Pharmaceuticals Inc., and Grunenthal GbmH v. Teva Pharmaceuticals USA, Inc., and Barr Laboratories, Inc.
Patents Involved
There are 6 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7851482
Method for making analgesics
|
Filed: 2007-10-03
Issued: 2010-12-14
|
Active (2.6 yrs remaining)
+646d PTA
Expires: 2029-07-10
|
|
|
US8114383
Abuse-proofed dosage form
|
Filed: 2003-11-20
Issued: 2012-02-14
|
Expired (Term Ended)
+325d PTA
Expires: 2024-10-10
|
|
|
US8309060
Abuse-proofed dosage form
|
Filed: 2012-01-09
Issued: 2012-11-13
|
Active (5.1 yrs remaining)
Expires: 2032-01-09
|
|
|
US8192722
Abuse-proof dosage form
|
Filed: 2008-06-17
Issued: 2012-06-05
|
Expired (Term Ended)
Expires: 2025-09-14
|
|
|
US8309122
Oxymorphone controlled release formulations
|
Filed: 2007-02-28
Issued: 2012-11-13
|
Expired (Term Ended)
Expires: 2026-03-08
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term; injunctive relief viable.
High PTA (+646 days) / In re Cellect scrutiny applies.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
16
Dispositive
1
Granted
4
Denied
0
Pending / Review
12
Motions by Category
Key Dispositive Motions & Rulings